{
    "eid": "2-s2.0-84896401100",
    "title": "Neurodegeneration in Parkinson's disease: Interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Neurology",
            "@code": "2808"
        },
        {
            "$": "Cellular and Molecular Neuroscience",
            "@code": "2804"
        },
        {
            "$": "Neuroscience (miscellaneous)",
            "@code": "2801"
        }
    ],
    "keywords": [
        "cAMP",
        "Depression",
        "Immuno-inflammation",
        "Neurodegeneration",
        "O&NS",
        "Parkinson's disease",
        "Somatization",
        "TRYCATs"
    ],
    "authors": [
        "George Anderson"
    ],
    "citedby-count": 78,
    "ref-count": 147,
    "ref-list": [
        "Parkinson's disease risk from ambient exposure to pesticides",
        "Epidemiology and etiology of Parkinson's disease: A review of the evidence",
        "The interplay between environmental and genetic factors in Parkinson's disease susceptibility: The evidence for pesticides",
        "CNS Neurol Dis Drug Targets",
        "Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-\u03b3",
        "Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-\u03b3-activated human macrophages: Posttranslational regulation by pyrrolidine dithiocarbamate",
        "Heme: A regulator of rat hepatic tryptophan 2,3-dioxygenase?",
        "\u03b2-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling",
        "Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons",
        "Is alpha-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases",
        "Circadian and sleep disorders in Parkinson's disease",
        "Psychiatric symptoms screening in the early stages of Parkinson's disease",
        "Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway",
        "Biological underpinnings of the commonalities in depression, somatization, and Chronic Fatigue Syndrome",
        "Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease",
        "Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra.",
        "Protective effect of l-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: Implications of modulating kynurenate as a protective strategy",
        "Kynurenines impair energy metabolism in rat cerebral cortex",
        "Quinolinic acid reduces the antioxidant defenses in cerebral cortex of young rats",
        "In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain",
        "Interleukin-1\u03b2: A new regulator of the kynurenine pathway affecting human hippocampal neurogenesis",
        "Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression",
        "Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: Focus on individual differences",
        "Plasma soluble interleukin-2-receptor in depression: relationships to plasma neopterin and serum IL-2 concentrations and HPA-axis activity",
        "The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): Relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation",
        "Colonic inflammation in Parkinson's disease",
        "Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system",
        "Increased neopterin production and tryptophan degradation in advanced Parkinson's disease",
        "Norepinephrine: the next therapeutics frontier for Parkinson's disease",
        "The locus coeruleus-norepinephrine network optimizes coupling of cerebral blood volume with oxygen demand",
        "Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia",
        "Protective effects of nicotine against aminochrome-induced toxicity in substantia nigra derived cells: Implications for Parkinson's disease",
        "Stimulation of non-\u03b17 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture",
        "Nicotine inhibits Fc\u03b5RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through \u03b17/\u03b19/\u03b110-nicotinic receptors",
        "Nicotine as a potential neuroprotective agent for Parkinson's disease",
        "Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: Implications for neuroprotection/neurodegeneration?",
        "Astrocyte mediated protection of fetal cerebral cortical neurons from rotenone and paraquat",
        "Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex of rat brain",
        "Alteration in glutathione content and associated enzyme activities in the synaptic terminals but not in the non-synaptic mitochondria from the frontal cortex of Parkinson's disease brains",
        "Glutathione and Parkinson's disease: Is this the elephant in the room?",
        "Potential of a \u03b3-Glutamyl-Transpeptidase-Stable Glutathione Analogue against Amyloid-\u03b2 Toxicity",
        "Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction",
        "Up-regulation of \u03b3-glutamyl transpeptidase activity following glutathione depletion has a compensatory rather than an inhibitory effect on mitochondrial complex I activity: implications for Parkinson's disease",
        "Localisation of novel forms of glutamate transporters and the cystine-glutamate antiporter in the choroid plexus: Implications for CSF glutamate homeostasis",
        null,
        "Cystine glutamate exchanger upregulation by retinoic acid induces neuroprotection in neural stem cells",
        "Am J Clin Exp Immunol",
        "Neuroimmune interactions in patients with inflammatory bowel diseases: Disease activity and clinical behavior based on Substance P serum levels",
        "Treatment with a substance p receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early parkinson's disease",
        "Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway",
        "Neuropeptides activate human mast cell degranulation and chemokine production",
        "Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: Substance P vs. dynorphin",
        "Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra",
        "Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms",
        "The circadian clock circuitry and the AHR signaling pathway in physiology and pathology",
        "Effect of dioxins on regulation of tyrosine hydroxylase gene expression by aryl hydrocarbon receptor: A neurotoxicology study",
        "Aryl hydrocarbon receptor ligand effects in RBL2H3 cells",
        "Presence and functional activity of the aryl hydrocarbon receptor in isolated murine cerebral vascular endothelial cells and astrocytes",
        "Identification of ketoconazole as an AhR-Nrf2 activator in cultured human keratinocytes: The basis of its anti-inflammatory effect",
        "Genetic ablation of the aryl hydrocarbon receptor causes cigarette smoke-induced mitochondrial dysfunction and apoptosis",
        "Interference of alpha-synuclein with cAMP/PKA-dependent CREB signaling for tyrosine hydroxylase gene expression in SK-N-BE(2)C cells",
        "Role of cAMP in mediating AHR signaling",
        "cAMP-dependent signaling as a core component of the mammalian circadian pacemaker",
        "Circadian modulation of gene expression, but not glutamate uptake, in mouse and rat cortical astrocytes",
        "Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson's disease",
        "A disruption mechanism of the molecular clock in a MPTP mouse model of parkinson's disease",
        "Circadian dysfunction in a mouse model of Parkinson's disease",
        "Association of Tef polymorphism with depression in Parkinson disease",
        "Promoter methylation analysis of seven clock genes in Parkinson's disease",
        null,
        "Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1\u03b1 signaling pathway",
        "IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology",
        "Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia",
        "Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease",
        "4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites",
        "Modulation of D1-like dopamine receptor function by aldehydic products of lipid peroxidation",
        "Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate",
        "Induction of KLF4 contributes to the neurotoxicity of MPP + in M17 cells: A new implication in Parkinson's disease",
        "4-hydroxynonenal inhibits SIRT3 via thiol-specific modification",
        "Sirtuin 3, a new target of PGC-1\u03b1, plays an important role in the suppression of ROS and mitochondrial biogenesis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Glasgow",
            "affilname": "CRC",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": []
}